Skip to main content
. 2014 Mar 19;348:g1888. doi: 10.1136/bmj.g1888

graphic file with name tayd015623.f14_default.jpg

Fig 14 Risk ratios for discontinuations because of adverse effects for agomelatine v another antidepressant. Weights are from random effects analysis